Wright Medical (NSDQ:WMGI) said it’s not optimistic about an FDA dispute resolution panel on its Augment biologic bone graft product, now slated for May, and would quickly move to cut costs at the BioMimetic Therapeutics subsidiary it bought back in 2012.
wrightmedical
Wright Medical closes OrthoPro purchase
Wright Medical (NSDQ:WMGI) said it closed the buyout of medical device maker OrthoPro, just a week after announcing the deal.
Salt Lake City-based OrthoPro makes devices to repair the foot and ankle; the acquisition is part of Memphis, Tenn.-based Wright’s move to focus on the extremities market.
Wright expands its footprint with $126M Solana Surgical, OrthoPro buys
NuVasive must face AngleFix patent infringement lawsuit
Wright Medical closes $290M OrthoRecon sale
2013 year in review: Our 5 most-read stories of the year
Wright Medical OrthoRecon sale to close early next month
Tennessee orthopedics company Wright Medical (NSDQ:WMGI) is preparing to put a ribbon on the sale of its OrthoRecon business, a deal in the works since June.
Wright Medical closes $80M Biotech International buyout
Wright Medical (NSDQ:WMGI) said the $80 million buyout of French orthopedic implant maker Biotech International it announced last month is on the books and could push its full-year sales to the higher end of its guidance.
FDA will hold dispute resolution panel for Wright Medical’s rejected Augment bone graft
Wright Medical (NSDQ:WMGI) officials said the FDA has agreed to hold a dispute resolution panel for the orthopedic company’s Augment Bone Graft product, which was denied approval by the agency in August.
Wright Medical shores up overseas extremities biz with $80M Biotech International buyout
Wright Medical (NSDQ:WMGI) said today that it agreed to pony up some $80 million for a French medical device company, Biotech International, that makes orthopedic devices for the extremities.
Wright Medical dives on non-approvable letter for Augment bone graft
Wright Medical (NSDQ:WMGI) shares are down nearly 9% today after the medical device company revealed that the FDA won’t approve its Augment bone graft.